CYP2J2 and coronary artery disorder: A large number of evidences demonstrated that polymorphisms in the CYP2J2 gene affect the risk and incidence of coronary heart disease in specific populations [51], and the plasma level of EETs is significantly elevated in patients with coronary artery disease without any change in DHETs levels [52].